Trivascular
Founded 1992 · 503 employees on LinkedIn · 3 known investors
Find your way into Trivascular
Endologix develops endovascular medical devices for treating vascular conditions such as abdominal aortic aneurysms and peripheral arterial disease in the femoropopliteal arteries. Its stent grafts and revascularization systems are used by physicians performing minimally invasive vascular repair.
Founders & leadership
JL
John LiddicoatPresident and Chief Executive Officer
GP
Graham PhillipsChief Operating Officer
CP
Cindy PintoChief Financial Officer
JO
Jorge O'HarainChief Commercial Officer
Investors · 3
Acquisitions · 1
Early investors' stakes continue via these dealsNellix Endovascular
Medical device company for aneurysm repair, acquired by Endologix.
In the news
Frequently asked questions
- What does Trivascular do?
- Endologix develops endovascular medical devices for treating vascular conditions such as abdominal aortic aneurysms and peripheral arterial disease in the femoropopliteal arteries. Its stent grafts and revascularization systems are used by physicians performing minimally invasive vascular repair.
- Who are Trivascular's investors?
- Trivascular's investors include 415 Capital, New Enterprise Associates (NEA), Deerfield Management Company.